Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Richters

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Future Medicinal Chemistry|October 28, 2017
Targeting protein arginine methyltransferase 5 in diseaseAndré Richters
Drug Discovery Today. Technologies|December 17, 2021
Structure-driven approaches and technologies for drug discoveryAndré Richters, Sven Hennig
Bioorganic & Medicinal Chemistry|May 16, 2015
Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFRDebjit Basu, André Richters, Daniel Rauh
Bioorganic & Medicinal Chemistry|July 22, 2020
Corrigendum to "Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR" [Bioorg. Med. Chem. 23, 2015, 2767-2780]Debjit Basu, André Richters, Daniel Rauh
ACS Chemical Biology|January 24, 2012
A chemical genetic approach for covalent inhibition of analogue-sensitive aurora kinaseAndré Koch, Haridas B Rode, André Richters, et al.
Methods in Enzymology|November 5, 2018
An Array-Based Ligand Discovery Platform for Proteins With Short Half-LivesBecky S Leifer, Shelby K Doyle, André Richters, et al.
Archiv Der Pharmazie|March 26, 2010
Proteus in the world of proteins: conformational changes in protein kinasesMatthias Rabiller, Matthäus Getlik, Sabine Klüter, et al.
Journal of Medicinal Chemistry|April 24, 2014
Identification of type II and III DDR2 inhibitorsAndré Richters, Hoang D Nguyen, Trang Phan, et al.
Journal of Medicinal Chemistry|October 18, 2013
Metabolically stable dibenzo[b,e]oxepin-11(6H)-ones as highly selective p38 MAP kinase inhibitors: optimizing anti-cytokine activity in human whole bloodBenjamin Baur, Kirsten Storch, Kathrin E Martz, et al.
Angewandte Chemie (International Ed. in English)|April 25, 2015
Neuritogenic militarinone-inspired 4-hydroxypyridones target the stress pathway kinase MAP4K4Peter Schröder, Tim Förster, Stefan Kleine, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Future Medicinal Chemistry|October 28, 2017
Targeting protein arginine methyltransferase 5 in diseaseAndré Richters
Drug Discovery Today. Technologies|December 17, 2021
Structure-driven approaches and technologies for drug discoveryAndré Richters, Sven Hennig
Bioorganic & Medicinal Chemistry|May 16, 2015
Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFRDebjit Basu, André Richters, Daniel Rauh
Bioorganic & Medicinal Chemistry|July 22, 2020
Corrigendum to "Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR" [Bioorg. Med. Chem. 23, 2015, 2767-2780]Debjit Basu, André Richters, Daniel Rauh
ACS Chemical Biology|January 24, 2012
A chemical genetic approach for covalent inhibition of analogue-sensitive aurora kinaseAndré Koch, Haridas B Rode, André Richters, et al.
Methods in Enzymology|November 5, 2018
An Array-Based Ligand Discovery Platform for Proteins With Short Half-LivesBecky S Leifer, Shelby K Doyle, André Richters, et al.
Archiv Der Pharmazie|March 26, 2010
Proteus in the world of proteins: conformational changes in protein kinasesMatthias Rabiller, Matthäus Getlik, Sabine Klüter, et al.
Journal of Medicinal Chemistry|April 24, 2014
Identification of type II and III DDR2 inhibitorsAndré Richters, Hoang D Nguyen, Trang Phan, et al.
Journal of Medicinal Chemistry|October 18, 2013
Metabolically stable dibenzo[b,e]oxepin-11(6H)-ones as highly selective p38 MAP kinase inhibitors: optimizing anti-cytokine activity in human whole bloodBenjamin Baur, Kirsten Storch, Kathrin E Martz, et al.
Angewandte Chemie (International Ed. in English)|April 25, 2015
Neuritogenic militarinone-inspired 4-hydroxypyridones target the stress pathway kinase MAP4K4Peter Schröder, Tim Förster, Stefan Kleine, et al.
Pageof 3